The Influence of Serum Leptin Level and Body Mass Index on the Prognosis of Patients with Diffuse Large B Cell Lymphoma

The Impact of Serum MicroRNA-21 on Outcome of Diffuse Large B-Cell Lymphoma Patients

High-Mobility Group Box 1 Protein (HMGB1) in Systemic Lupus Erythematosus: Review Article

High-Mobility Group Box 1 Protein (HMGBl): Role in Lupus Nephritis

High-mobility group box 1, early activity marker in lupus nephritis

The Association of Mean Platelet Volume and Red Cell Distribution Width with Disease Free Survival in Diffuse Large B Cell Lymphoma

The Role of Cell-Free DNA as a Prognostic Marker in Diffuse Large B Cell Lymphoma with Hepatitis C

Serum miR-26a-5p and miR-199b-5p as a biomarker to predict therapy for Diffuse Large B-cell lymphoma with Hepatitis C Infection

Clinicopathological Significance of A20 Genetic Mutation in Diffuse Large B-Cell Lymphoma

CA 125 LEVELS IN B CELL NON HODGKIN LYMPHOMA